Decreased adiponectin production exerts a key role in the pathogenesis of obesity-associated disorders: arterial hypertension, metabolic syndrome, atherosclerosis, and cancer [109,110,111]. This evidence concerns the gene ADIPOQ and obesity due to melanocortin 4 receptor deficiency.